𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fentanyl-induced dyskinesias

✍ Scribed by Giselle Petzinger; Stephan A. Mayer; Serge Przedborski

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
249 KB
Volume
10
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa-induced dyskinesias
Levodopa-induced dyskinesias
✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do

Moyamoya-induced paroxysmal dyskinesia
Moyamoya-induced paroxysmal dyskinesia
✍ Pedro Gonzalez-Alegre; Zakaria Ammache; Patricia H. Davis; Robert L. Rodnitzky 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract Moyamoya disease (MMD) is an uncommon intracranial vasculopathy that typically presents with ischemic or hemorrhagic stroke. Persistent choreoathetosis has been identified as a rare early manifestation of MMD. We present 2 patients with paroxysmal dyskinesia as the initial symptom of MM

Adrafinil-induced orofacial dyskinesia
Adrafinil-induced orofacial dyskinesia
✍ Stéphane Thobois; Jing Xie; Helena Mollion; Isabelle Benatru; Emmanuel Broussoll 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

## Abstract We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically i

Phenytoin potentiation of neuroleptic-in
Phenytoin potentiation of neuroleptic-induced dyskinesias
✍ K. D. Sethi; Ana Hitri; Bruce I. Diamond 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

## Abstract Clinically phenytoin‐induced movement disorders may resemble neuroleptic‐induced tardive dyskinesia (TD). Neuroleptic‐induced TD is thought to be related to an increase in the number and affinity of dopamine D~2~ receptors. We investigated the interaction of phenytoin with dopaminergic